Inpatient and Outpatient Orderable

Ovarian Malignancy Risk (ROMA) Build info

Synonyms

  • OVARIAN MALIGNANCY RISK (ROMA)
  • LAB10853

Short Name

OVARIAN MALIGNANCY RISK (ROMA)

Procedure Master Number

LAB10853

Procedure ID

114214

Clinical Info

The ROMA™ (Risk of Ovarian Malignancy Algorithm) calculation combines the results of the Roche Elecsys HE4 assay, Elecsys CA 125 II assay and menopausal status into a numerical score (Roche). The ROMA value is intended to aid in assessing whether a premenopausal or postmenopausal woman who presents with an ovarian adnexal mass is at high or low likelihood of finding malignancy on surgery.

Specimen Sources

Blood, Arterial Blood, Capillary Blood, Central Line Blood, Venous

Specimen Types

Blood

Container

Gold Top Tube

Collection Instructions

Container/Tube: Gold Top or Red top tube
Specimen: 1.75 ml Serum (1.0 mL min-this volume does not allow for repeat testing)
Transport Temperature: Refrigerated  -Stable for 14 Days
 
Note: This test may exhibit interference when sample is collected from a person who is consuming a supplement with a high dose of biotin (also termed as vitamin B7 or B8, vitamin H, or coenzyme R). It is recommended to ask all patients who may be indicated for this test about biotin supplementation. Patients should be cautioned to stop biotin consumption at least 72 hours prior to the collection of a sample.

Transport Instructions

Refrigerated  -Stable for 14 Days

Specimen Stability

5 Days Room Temperature
14 Days Refrigerated

Methodology

Electrochemiluminescence immunoassay (ECLIA)

Days Performed

Performing Laboratory

LabCorp of America

CPT

81500

PDM

5904898

Only Orderable at Locations:

Orderable Everywhere

Results

Component Name Base Name Common Name External Name
CA 125 (LABCORP) CA125 CA 125 LABCORP Ca 125 (Labcorp)
HE 4 HE4 HE 4 He 4
PREMENOPAUSAL ROMA PREMENROMA PREMENOPAUSAL ROMA Premenopausal Roma
POSTMENOPAUSAL ROMA POSMENROMA POSTMENOPAUSAL ROMA Postmenopausal Roma
ROMA COMMENT ROMACOM ROMA COMMENT Roma Comment